<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01824472</url>
  </required_header>
  <id_info>
    <org_study_id>814153</org_study_id>
    <secondary_id>R34HL109462</secondary_id>
    <nct_id>NCT01824472</nct_id>
  </id_info>
  <brief_title>Understanding the Sleep Apnea/Insomnia Interaction</brief_title>
  <official_title>Understanding the Sleep Apnea/Insomnia Interaction: a CPAP/Sham-CPAP Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nearly half of all patients with obstructive sleep apnea have insomnia symptoms, and in some,
      but not all cases, these insomnia symptoms are caused by the obstructive sleep apnea. The
      purpose of this study is to find out what type of insomnia symptoms are caused by obstructive
      sleep apnea and therefore most likely to respond to obstructive sleep apnea treatment with
      continuous positive airway pressure (also known as CPAP) and if additional treatment with
      cognitive-behavioral therapy for insomnia is beneficial.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2013</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insomnia Severity Index Score</measure>
    <time_frame>Day 42</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Sleep Apnea Syndromes</condition>
  <condition>Sleep Initiation and Maintenance Disorders</condition>
  <arm_group>
    <arm_group_label>CPAP+CC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CPAP therapy for sleep apnea and contact control (placebo/sham for cognitive-behavioral therapy for insomnia)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham CPAP+CC</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>sham CPAP (ineffective CPAP--placebo/sham for sleep apnea) and contact control (placebo/sham for cognitive-behavioral therapy for insomnia)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPAP+CBT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CPAP therapy for sleep apnea and cognitive-behavioral therapy for insomnia</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <description>Treatment for sleep apnea</description>
    <arm_group_label>CPAP+CC</arm_group_label>
    <arm_group_label>CPAP+CBT</arm_group_label>
    <other_name>Continuous positive airway pressure therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CBT</intervention_name>
    <description>Treatment for insomnia</description>
    <arm_group_label>CPAP+CBT</arm_group_label>
    <other_name>Cognitive-Behavioral Therapy for Insomnia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham CPAP</intervention_name>
    <description>Placebo for sleep apnea</description>
    <arm_group_label>sham CPAP+CC</arm_group_label>
    <other_name>Sham (placebo) continuous positive airway pressure</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CC</intervention_name>
    <description>Placebo (sham) for insomnia</description>
    <arm_group_label>CPAP+CC</arm_group_label>
    <arm_group_label>sham CPAP+CC</arm_group_label>
    <other_name>Contact control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Sleep Apnea

          2. Insomnia

          3. Age &gt;18

        Exclusion Criteria:

          1. Sedative/psychoactive drug use recently

          2. Other clinically significant sleep disorders

          3. Previous treatment for OSA

          4. Requires oxygen or bilevel PAP therapy

          5. Clinically unstable medical condition

          6. Recent shift work

          7. Significant alcohol use

          8. Other clinically significant causes of insomnia

          9. Illicit drug use

         10. Prescription stimulants

         11. Safety restrictions

         12. Unable to treat sleep apnea with positive airway pressure therapy

         13. Communication barriers

         14. Cognitive impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Pennsylvania Health System</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2013</study_first_submitted>
  <study_first_submitted_qc>April 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2013</study_first_posted>
  <last_update_submitted>May 3, 2017</last_update_submitted>
  <last_update_submitted_qc>May 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

